Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lennart Bunch

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|October 27, 2006
Stereoselective chemoenzymatic synthesis of the four stereoisomers of l-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3Sophie Faure, Anders A Jensen, Vincent Maurat, et al.
Chemmedchem|August 29, 2012
Gram-scale solution-phase synthesis of selective sodium bicarbonate co-transport inhibitor S0859: in vitro efficacy studies in breast cancer cellsAnn M Larsen, Niels Krogsgaard-Larsen, Gitte Lauritzen, et al.
Biological Chemistry|November 25, 2022
<i>In vitro</i> ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugsElena Bechthold, Lucie Grey, Emil Diamant, et al.
Journal of Medicinal Chemistry|June 27, 2008
Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7Emanuelle Sagot, Darryl S Pickering, Xiaosui Pu, et al.
Journal of Medicinal Chemistry|September 15, 2016
Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure-Activity Relationship StudyStinne W Hansen, Mette N Erichsen, Bingru Fu, et al.
European Journal of Medicinal Chemistry|February 18, 2014
Synthesis of (3-hydroxy-pyrazolin-5-yl)glycine based ligands interacting with ionotropic glutamate receptorsAndrea Pinto, Lucia Tamborini, Federica Mastronardi, et al.
Journal of Medicinal Chemistry|January 3, 2024
Design, Synthesis, Pharmacology, and In Silico Studies of (1<i>S</i>,2<i>S</i>,3<i>S</i>)-2-((<i>S</i>)-Amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic Acid (LBG30300): A Picomolar Potency Subtype-Selective mGlu<sub>2</sub> Receptor AgonistNa Liu, Floriane Eshak, Fanny Malhaire, et al.
Neurochemical Research|April 1, 2014
Probing for improved potency and in vivo bioavailability of excitatory amino acid transporter subtype 1 inhibitors UCPH-101 and UCPH-102: design, synthesis and pharmacological evaluation of substituted 7-biphenyl analogsMette N Erichsen, Jeanette Hansen, Josep A Ruiz, et al.
Chemmedchem|July 22, 2014
Molecular recognition of two 2,4-syn-functionalized (S)-glutamate analogues by the kainate receptor GluK3 ligand binding domainRaminta Venskutonytė, Anja P Larsen, Karla Frydenvang, et al.
Journal of Medicinal Chemistry|December 17, 2021
Derivatives of (<i>R</i>)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|October 27, 2006
Stereoselective chemoenzymatic synthesis of the four stereoisomers of l-2-(2-carboxycyclobutyl)glycine and pharmacological characterization at human excitatory amino acid transporter subtypes 1, 2, and 3Sophie Faure, Anders A Jensen, Vincent Maurat, et al.
Chemmedchem|August 29, 2012
Gram-scale solution-phase synthesis of selective sodium bicarbonate co-transport inhibitor S0859: in vitro efficacy studies in breast cancer cellsAnn M Larsen, Niels Krogsgaard-Larsen, Gitte Lauritzen, et al.
Biological Chemistry|November 25, 2022
<i>In vitro</i> ADME characterization of a very potent 3-acylamino-2-aminopropionic acid-derived GluN2C-NMDA receptor agonist and its ester prodrugsElena Bechthold, Lucie Grey, Emil Diamant, et al.
Journal of Medicinal Chemistry|June 27, 2008
Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7Emanuelle Sagot, Darryl S Pickering, Xiaosui Pu, et al.
Journal of Medicinal Chemistry|September 15, 2016
Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure-Activity Relationship StudyStinne W Hansen, Mette N Erichsen, Bingru Fu, et al.
European Journal of Medicinal Chemistry|February 18, 2014
Synthesis of (3-hydroxy-pyrazolin-5-yl)glycine based ligands interacting with ionotropic glutamate receptorsAndrea Pinto, Lucia Tamborini, Federica Mastronardi, et al.
Journal of Medicinal Chemistry|January 3, 2024
Design, Synthesis, Pharmacology, and In Silico Studies of (1<i>S</i>,2<i>S</i>,3<i>S</i>)-2-((<i>S</i>)-Amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic Acid (LBG30300): A Picomolar Potency Subtype-Selective mGlu<sub>2</sub> Receptor AgonistNa Liu, Floriane Eshak, Fanny Malhaire, et al.
Neurochemical Research|April 1, 2014
Probing for improved potency and in vivo bioavailability of excitatory amino acid transporter subtype 1 inhibitors UCPH-101 and UCPH-102: design, synthesis and pharmacological evaluation of substituted 7-biphenyl analogsMette N Erichsen, Jeanette Hansen, Josep A Ruiz, et al.
Chemmedchem|July 22, 2014
Molecular recognition of two 2,4-syn-functionalized (S)-glutamate analogues by the kainate receptor GluK3 ligand binding domainRaminta Venskutonytė, Anja P Larsen, Karla Frydenvang, et al.
Journal of Medicinal Chemistry|December 17, 2021
Derivatives of (<i>R</i>)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Pageof 7